Literature DB >> 32883411

Association of Family History With Incidence and Outcomes of Aortic Dissection.

Shao-Wei Chen1, Chang-Fu Kuo2, Yu-Tung Huang3, Wan-Ting Lin3, Victor Chien-Chia Wu4, An-Hsun Chou5, Pyng-Jing Lin6, Shang-Hung Chang7, Pao-Hsien Chu8.   

Abstract

BACKGROUND: Aortic dissection (AD) is a life-threatening emergency. However, the heritability and association of family history with late outcomes are unclear.
OBJECTIVES: The purpose of this study was to evaluate the effect of family history of AD on the incidence and prognosis of AD and estimate the heritability and environmental contribution in AD in Taiwan.
METHODS: Both cross-sectional and cohort studies were conducted using Taiwan National Health Insurance database. A registry parent-offspring relationship algorithm was used to reconstruct the genealogy of this population for heritability estimation. The cross-sectional study included 23,868 patients with a diagnosis of AD in 2015. The prevalence and adjusted relative risks (RRs) were evaluated, and the liability threshold model was used to examine the effects of heritability and environmental factors. Furthermore, a 1:10 propensity score-matched cohort comprising AD patients with or without a family history of AD was included to compare late outcomes in the cohort study.
RESULTS: A family history of AD in first-degree relatives was associated with an RR of 6.82 (95% confidence interval [CI]: 5.12 to 9.07). The heritability of AD was estimated to be 57.0% for genetic factors, and 3.1% and 40.0% for shared and nonshared environmental factors, respectively. After excluding individuals with Marfan syndrome or bicuspid aortic valve, a family history of AD was associated with an RR of 6.56 (95% CI: 4.92 to 8.77) for AD. Furthermore, patients with AD and a family history of AD had a higher risk of later aortic surgery than those with AD without a family history (subdistribution hazard ratio: 1.40; 95% CI: 1.12 to 1.76).
CONCLUSIONS: A family history of AD was a strong risk factor for AD. Furthermore, patients with AD with a family history of AD had a higher risk of later aortic surgery than those with no family history of AD.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aortic dissection; family aggregation; family history; long-term prognosis

Year:  2020        PMID: 32883411     DOI: 10.1016/j.jacc.2020.07.028

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  The Expression Patterns and Roles of Lysyl Oxidases in Aortic Dissection.

Authors:  Xin Yi; Yi Zhou; Yue Chen; Xin Feng; Chang Liu; Ding-Sheng Jiang; Jing Geng; Xiaoyan Li; Xuejun Jiang; Ze-Min Fang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

2.  Preventing Acute Aortic Dissections: The Power of Familial Screening and Risk Assessment.

Authors:  Alana C Cecchi; Maura L Boerio; Isabella Marin; Amélie Pinard; Dianna M Milewicz
Journal:  J Am Heart Assoc       Date:  2022-04-06       Impact factor: 6.106

3.  Sex-related differences on the risks of in-hospital and late outcomes after acute aortic dissection: A nationwide population-based cohort study.

Authors:  Fang-Ting Chen; An-Hsun Chou; Yi-Hsin Chan; Victor Chien-Chia Wu; Chia-Pin Lin; Kuo-Chun Hung; Pao-Hsien Chu; Yu-Ting Cheng; Shao-Wei Chen
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

Review 4.  Current state and future directions of genomic medicine in aortic dissection: A path to prevention and personalized care.

Authors:  Alana C Cecchi; Madeline Drake; Chrisanne Campos; Jake Howitt; Jonathan Medina; Scott M Damrauer; Sherene Shalhub; Dianna M Milewicz
Journal:  Semin Vasc Surg       Date:  2022-02-25       Impact factor: 1.222

5.  Ischemic Stroke Due to Spontaneous Dissection of the Brachiocephalic to the Common Carotid Artery with a Fatal Course after Expansion to the Ascending Aorta.

Authors:  Kazumasa Oura; Mitsunobu Sato; Mao Yamaguchi Oura; Ryo Itabashi; Tetsuya Maeda
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.